Article Text
Therapeutics/Prevention
Randomised controlled trial
Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment
Statistics from Altmetric.com
Footnotes
Contributors GWR wrote the manuscript. AA contributed to the analysis, reviewed and approved the manuscript.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.